Tissue Hypoxia and Topical Oxygen Therapy in Ocular Mustard Gas Injury
眼芥子气损伤的组织缺氧和局部氧疗
基本信息
- 批准号:10630652
- 负责人:
- 金额:$ 24.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAlkaliesAnimalsApoptosisAtmosphereBlindnessBullaCataractCellsChemical InjuryChemical WeaponsCorneaCorneal NeovascularizationDataDefectEdemaEmulsionsEnabling FactorsEngineeringEpithelial CellsEquipmentEventExposure toEyeEye InjuriesEye diseasesEyelid structureFibrosisFluoresceinGoalsGrantHIF1A geneHistologicHumanHypoxiaHypoxia Inducible FactorIn VitroInflammationInflammatoryInjectionsInjuryKnowledgeLeucocytic infiltrateMechlorethamineMediatingMucous MembraneMusMustard GasOxidative StressOxygenOxygen Therapy CarePainPenetrationProductionProliferatingResearchRoleSignal TransductionSkin TissueStainsStructure of parenchyma of lungTemperatureTestingTherapeuticTimeTissuesTopical applicationTrainingTreatment EfficacyVisual impairmentWorkchemical threatcorneal epitheliumcytokineeffective therapyefficacy evaluationexposed human populationhealingin vivolimbalmass casualtymouse modelneovascularizationnerve supplynovelportabilitypressureslit lamp imagingstem cellstargeted treatmenttranscription factorweapons of mass destruction
项目摘要
Mustard gas (MG, most commonly sulfur mustard and nitrogen mustard) is a chemical weapon of mass
destruction and a vesicating agent capable of penetrating mucous membranes. Ocular exposure to MG leads
to eyelid edema, conjunctival injection and chemosis, corneal epithelial defect, opacification, and
neovascularization (NV), limbal stem cell deficiency, and cataract formation, resulting in pain, visual
impairment, and blindness. Despite numerous studies in human and animals, the underlying mechanisms of
MG eye injury are not clear, and to date there is no targeted treatment. Hypoxia and inflammation are
intertwining mechanisms mediating tissue damage after burn including chemical injuries. Tissue hypoxia is an
important mechanism underlying skin and lung tissue damages after MG exposure. In our preliminary study,
we found that ocular alkali burn leads to significant intraocular tissue hypoxia, resulting in the activation of
hypoxia-inducible factor (HIF) signaling, oxidative stress, and inflammation in vivo. In addition, exposure of
human corneal epithelial cells to nitrogen mustard promotes HIF signaling in vitro. However, the role of tissue
hypoxia in ocular MG exposure in vivo has not been studied. We have engineered a perfluorodecalin-based
supersaturated oxygen emulsion (SSOE) as a topical treatment to deliver high levels (over 4 times of
atmospheric levels) of oxygen to the eye. In our preliminary work, we found that a single topical application of
SSOE at time of acute alkali burn drastically reduces intraocular hypoxia and dampens HIF signaling, oxidative
stress, and inflammation. SSOE accelerates corneal epithelial healing and ameliorates corneal opacification,
cataract formation, and tissue fibrosis in vivo. Our overarching goal in this application is to identify the
role of tissue hypoxia and inflammation in MG eye injury and to determine the efficacy of SSOE in
treating MG-related ocular damages. We have established a novel mouse model of ocular nitrogen mustard
exposure and plan to test the following aims: In Specific Aim 1, we hypothesize that tissue hypoxia occurs
rapidly after MG exposure, and we will determine intraocular oxygen levels, HIF signaling, oxidative stress, and
tissue inflammation after ocular nitrogen mustard exposure in vivo; In Specific Aim 2, we hypothesize that
SSOE treatment will reverse tissue hypoxia and reduce inflammation after MG exposure, and will determine
the efficacy of SSOE application in mitigating nitrogen mustard eye injury by assessing tissue hypoxia,
oxidative stress, leukocyte infiltration, tissue fibrosis, corneal opacification/NV, and cataract formation in vivo.
Successful completion of this proposal will not only fill in the knowledge gap in MG injury-related hypoxia
research but provide first proof-of-concept data in demonstrating the therapeutic potential of SSOE as a novel
topical treatment for acute MG exposure. Given that SSOE is formulated to be portable in a small canister and
stable at room temperature, it can potentially be stockpiled and rapidly deployed in a mustard gas attack with
mass casualty and provide countermeasure against chemical threats currently without any treatment options.
芥子气(MG,最常见的是硫芥子气和氮芥子气)是一种大规模化学武器
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jia Yin其他文献
Jia Yin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jia Yin', 18)}}的其他基金
Mechanisms of Neuroregulation of Corneal Angiogenesis
角膜血管生成的神经调节机制
- 批准号:
10186760 - 财政年份:2020
- 资助金额:
$ 24.63万 - 项目类别:
Mechanisms of Neuroregulation of Corneal Angiogenesis
角膜血管生成的神经调节机制
- 批准号:
10649841 - 财政年份:2020
- 资助金额:
$ 24.63万 - 项目类别:
Mechanisms of Neuroregulation of Corneal Angiogenesis
角膜血管生成的神经调节机制
- 批准号:
10469573 - 财政年份:2020
- 资助金额:
$ 24.63万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 24.63万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 24.63万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 24.63万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 24.63万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 24.63万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 24.63万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 24.63万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 24.63万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 24.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 24.63万 - 项目类别:
Standard Grant














{{item.name}}会员




